APA (7th ed.) Citation

Müller, K., Vogiatzi, F., Winterberg, D., Rösner, T., Lenk, L., Bastian, L., . . . Schewe, D. M. (2022). Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL. Blood, 140(1), . https://doi.org/10.1182/blood.2021014485

Chicago Style (17th ed.) Citation

Müller, Kristina, et al. "Combining Daratumumab with CD47 Blockade Prolongs Survival in Preclinical Models of Pediatric T-ALL." Blood 140, no. 1 (2022). https://doi.org/10.1182/blood.2021014485.

MLA (9th ed.) Citation

Müller, Kristina, et al. "Combining Daratumumab with CD47 Blockade Prolongs Survival in Preclinical Models of Pediatric T-ALL." Blood, vol. 140, no. 1, 2022, https://doi.org/10.1182/blood.2021014485.